Evidence map›Paper›PMID 42355564›Full record

ArticleLife (Basel, Switzerland)2026

Blood Group Antigen Combinations and COVID-19: Complexity, Associations and Possible Clinical Relevance.

Jolanta Wrobel, Ewa Jablonska, Krzysztof Matuk, Agnieszka Zebrowska, Piotr Radziwon, Wioletta Ratajczak-Wrona

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jolanta WrobelRegional Centre for Transfusion Medicine, 15-950 Bialystok, Poland.
Ewa JablonskaDepartment of Immunology, Medical University of Bialystok, ul. J. Waszyngtona 15A, 15-269 Bialystok, Poland.ORCID 0000-0001-7899-7830
Krzysztof MatukImago Sp. z o.o., ul. Przedzalniana 6L lok. 14, 15-688 Bialystok, Poland.
Agnieszka ZebrowskaRegional Centre for Transfusion Medicine, 15-950 Bialystok, Poland.
Piotr RadziwonRegional Centre for Transfusion Medicine, 15-950 Bialystok, Poland.
Wioletta Ratajczak-WronaDepartment of Immunology, Medical University of Bialystok, ul. J. Waszyngtona 15A, 15-269 Bialystok, Poland.ORCID 0000-0002-7634-0875

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of the study was to investigate whether red blood cell antigens (A, B, D, C

methodsThis exploratory case-control study was carried out on a group of 263 donors from the Regional Center for Transfusion Medicine, Bialystok, Poland (including 121 convalescents and 142 healthy subjects). The microplate method was applied to examine the expression of 21 antigens from eight clinically relevant systems in the donors' red blood cells.

resultsNo significant correlation was found between any single blood group and susceptibility to COVID-19. For a more detailed analysis, we adopted an approach involving 3-, 4- and 5-element mutual combinations of antigens. In this exploratory analysis of multi-antigen combinations, nominal statistical significance was found for a number of associations, but none remained statistically significant after adjustment for multiple testing. In the case of three-antigen associations, the strongest association was observed for cc combined with Ee and kk, with the effect size showing approximately 4× higher odds of COVID-19 (OR = 4.49,

conclusionsThe findings suggest that analyses based solely on single blood group antigens may have limited value for assessing the susceptibility to COVID-19. In contrast, combinations of red blood cell antigens may provide more reliable correlations with the susceptibility to COVID-19. However, these findings should be interpreted with caution and require confirmation on larger and more representative populations.

Indexed as

COVID-19group antigens

Identifiers

PMID42355564
PMCPMC13300998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.